Buff Gold Ventures

Polaris Electro-Optics specializes in the manufacture of ferroelectric nematic liquid crystals for electro-optic modulators. Utilizing patented material and design innovations, the company offers high-speed, energy-efficient integrated photonics products, serving the communications and computation industries.

Founded in 2020, Tynt Technologies specializes in developing smart windows that minimize glare while preserving views. These windows enhance occupant comfort and significantly reduce energy consumption from lighting and HVAC systems.

LongPath Technologies develops laser-based monitoring solutions for the oil and gas sector. The company offers long-range laser systems and managed infrastructure for continuous emissions monitoring across large areas, capable of detecting leaks and identifying the absorption fingerprints of multiple molecules. This enables emission source identification and rate quantification in a cost-effective manner, helping operators validate gas performance and support safer, more sustainable operations.

Vitro3D develops high dimensionality volumetric additive manufacturing (HD-VAM) technology to enable high‑resolution, rapid production of parts with a broad range of material properties. By integrating advanced hardware, software, and novel material formulations, it enables production with minimal post‑processing. The company pursues a platform approach that aims to deliver fast, reliable, and sustainable part manufacture for manufacturers, reducing time, cost, and workflow steps. Its technology supports diverse applications across industries requiring complex shapes and varied material properties, positioning Vitro3D as a leader in volumetric 3D printing.

Think Bioscience is a company focused on advancing synthetic biology to enhance the development of medicines. It employs innovative technology to encode complex molecular objectives within microbial hosts, facilitating the identification, construction, and evolution of small molecules. By leveraging living systems, Think Bioscience aims to transform the drug discovery process, providing medical researchers with powerful tools to create better therapeutic solutions. The company's approach represents a significant evolution in the field of synthetic biology, positioning it as a leader in the quest for improved medicinal outcomes.